Furthermore, analyses of TCGA data indicated that high expression of both subunits of xCT was significantly associated with poor overall survival (Figure 1g) and disease-free survival (Figure 1h) in patients with breast cancer. This evidence concerns the gene SLC7A11 and breast carcinoma.